)
Edge20 Feb 2026
Dollar General: The Rural Retailer Playbook
How Dollar General built a small-box empire across rural America, scaling value and convenience into one of retail's most durable business models.
Cytek Biosciences
Cytek Biosciences (CTKB) investor relations material
Cytek Biosciences Q4 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q4 2025 earnings summary26 Feb, 2026
Executive summary
Achieved record Q4 2025 revenue of $62.1M, up 8% year-over-year, and full-year revenue of $201.5M, up 1% year-over-year, despite challenging industry conditions.
Recurring revenue grew 21% in 2025, now comprising 34% of total revenue.
Growth driven by stabilization in the U.S., turnaround in EMEA, and continued strength in APAC, with recurring revenue and new product launches contributing.
Expanded installed base to 3,664 instruments, with 630 new placements in 2025; Aurora Evo and Muse Micro cell analyzer launched, with Muse Micro winning a 2025 industry award.
Established a new manufacturing facility in Singapore, enhancing supply chain resilience and mitigating tariff impacts.
Financial highlights
Q4 2025 revenue reached $62.1M (+8% YoY); full-year revenue was $201.5M (+1% YoY).
Q4 GAAP gross profit was $32.9M (53% margin), down from $33.7M (59%) YoY; adjusted gross margin was 55% (down from 61%).
Full-year 2025 GAAP gross profit was $104.5M, down 6% YoY; gross margin fell to 52% from 55%.
Q4 net loss was $44.1M, including a $38.1M non-cash deferred tax asset write-off; full-year net loss was $66.5M.
Adjusted EBITDA for Q4 was $4.5M, down from $12.5M YoY; full-year adjusted EBITDA was $5M, down from $22.4M.
Cash and marketable securities at year-end totaled $261.5M, after $15.1M in stock repurchases.
Outlook and guidance
2026 revenue guidance set at $205M–$212M, reflecting 2–5% growth, assuming constant currency and no major tariff changes.
Expect continued strong growth in service and reagents, with flat to modest growth in instruments.
Anticipate positive adjusted EBITDA in 2026, with ongoing investment in commercial and reagent sales teams.
Outlook for biopharma instrument demand
Tariff policy impact on 2026 margins
Instrument growth assumptions for 2026
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Cytek Biosciences earnings date
TD Cowen 46th Annual Health Care Conference4 Mar, 2026
Cytek Biosciences
Next Cytek Biosciences earnings date
TD Cowen 46th Annual Health Care Conference4 Mar, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Cytek Biosciences Inc. is a biotechnology company specializing in cell analysis solutions. The company develops and manufactures flow cytometry instruments, reagents, and software used in biomedical research and clinical diagnostics. Cytek’s technologies enable the study of cell characteristics, functions, and biomarkers, supporting research in immunology, oncology, and other areas of life sciences. The company serves academic institutions, pharmaceutical companies, and clinical laboratories, providing tools for advanced cellular analysis and discovery. The company is headquartered in Fremont, California, and its shares are listed on the NASDAQ.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage